Investigation of the Muscle Oxygenation in Patients With Post COVID-19 Syndrome

NCT05957575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2023-08-02

No results posted yet for this study

Summary

More than 60% of patients infected with COVID-19 have long-term symptoms. These symptoms are associated with common ground-glass opacities on computed tomography scans and chest radiographs. The pathophysiology of long-term persistent symptoms is largely unknown, but hypoxia and hypoxic tissue damage, decreased pulmonary diffusion capacity, ventilation-perfusion mismatch, and lung fibrosis caused by COVID-19-associated pneumonia are thought to cause long-term symptoms. Desaturation may occur during exercise due to hypoxia, pneumonia and lung involvement in patients with post-COVID syndrome. Oxygenation of peripheral muscles may decrease due to hypoxemia, but there is not enough study on this subject yet.

Conditions

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Başak KAVALCI KOL, Pt. MSc. · Gazi University

  • Ece BAYTOK, Pt. MSc. · Gazi University

  • Nilgün YILMAZ DEMİRCİ, Assoc. Prof. · Gazi University

  • Meral BOŞNAK GÜÇLÜ, Prof. Dr. · Gazi University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-25
Primary Completion
2023-06-15
Completion
2023-07-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05957575 on ClinicalTrials.gov